Madden Securities’s DexCom DXCM Stock Holding History

Madden Securities’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-336	Closed	-$38K	–	167
2022 Q4	$38K	Buy	+336	New	+$36.9K	0.02%	221

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Madden Securities's DXCM Position: Q1 2023 in Review

Madden Securities sold out of DexCom (DXCM) in Q1 2023, closing a stake of 336 shares — an estimated $38K sold.

Madden Securities first reported a position in DXCM in Q4 2022 and held it in 1 quarter. The position peaked at $38K in Q4 2022. 904 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

Madden Securities reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
Madden Securities sold 336 DexCom shares in Q1 2023, an estimated $38K.
Madden Securities first reported a position in DexCom in Q4 2022 and held it in 1 quarter.
Madden Securities's DexCom position peaked at $38K in Q4 2022.
904 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Madden Securities's 13F filing for Q1 2023, filed 21 Apr 2023.